We’re putting the EMPHASIS back on CELIAC DISEASE .

Patients can match trials through the new search on the Beyond Celiac clinical trials page powered by Antidote

Celiac disease patients report they experience more than just GI symptoms, growing dissatisfaction with the gluten-free diet as a sufficient treatment

After being diagnosed with celiac disease you may be asking yourself, “Is ingesting a small amount of gluten occasionally really that harmful?” or maybe you are thinking “Surely it won’t hurt to indulge in a few bites during the holidays.” It’s common to wonder these things when you are diagnosed with celiac disease.

This year, we hosted another community survey to learn more about you and your experiences with living with celiac disease and non-celiac gluten sensitivity. Check out the preliminary results in this article!

Highlighting the need for a cure on National Celiac Disease Awareness Day

Genetic tests can reveal more than a simple “yes” or “no” regarding whether an at-risk child has the genes associated with celiac disease.

Two drugs currently under study for the treatment of celiac disease are part of new collaborations between pharmaceutical companies which could result in acceleration of the drugs’ progress.

A wide-spread screening study estimates that nearly 1.5 percent of the residents of one Norwegian county have celiac disease, and before the screening, 75 percent didn’t realize it

The vaccine for rotavirus does not increase or decrease the risk that a child will develop celiac disease, according to a new study from researchers at the University of Michigan.

Even on a gluten-free diet, more than half of those with celiac disease continue to have symptoms, often the same ones that led to diagnosis.

Ask a Dietitian: What are dietary supplements you would recommend for a patient diagnosed with celiac disease?

Foods for when you suffer from both celiac disease and diverticulitis

Monitoring celiac disease

How to tell if ongoing symptoms are from celiac disease

What’s the point of follow-up testing and monitoring?

Cystic fibrosis patients banded together and changed the future for those living with the disease. Can increased patient participation produce similar results for celiac disease?

Monoclonal antibodies can be used for treating many different types of disease and are being studied in celiac disease after showing proof-of-concept in earlier trials

PRV-015 has previously been studied for its potential to reduce symptoms and inflammation triggered by gluten in people with celiac disease.

Latiglutenase development continues with initial CeliacShield™ study results and ongoing Solutions for Celiac™ clinical study actively recruiting participants

Celiac disease community is an integral part of research into this potential immune tolerance treatment